These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 24858734)
1. Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Choi JS; Kim EK; Moon HJ; Kwak JY Endocrine; 2015 Feb; 48(1):264-71. PubMed ID: 24858734 [TBL] [Abstract][Full Text] [Related]
2. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma. Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312 [TBL] [Abstract][Full Text] [Related]
3. Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma. Yoon JH; Park JY; Hong AR; Kim HK; Kang HC Front Endocrinol (Lausanne); 2024; 15():1392247. PubMed ID: 39015180 [TBL] [Abstract][Full Text] [Related]
5. Gray-scale ultrasonography combined with elastography imaging for the evaluation of papillary thyroid microcarcinoma: as a prognostic clinicopathology factor. Jin ZQ; Lin MY; Hu WH; Li WY; Bai SJ Ultrasound Med Biol; 2014 Aug; 40(8):1769-77. PubMed ID: 24768485 [TBL] [Abstract][Full Text] [Related]
6. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma. Gao Y; Qu N; Zhang L; Chen JY; Ji QH Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma. Kim WY; Kim HY; Son GS; Bae JW; Lee JB J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486 [TBL] [Abstract][Full Text] [Related]
8. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases. Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725 [TBL] [Abstract][Full Text] [Related]
9. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
10. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension. Zhang X; Zhang L; Xue S; Wang P; Chen G Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501 [TBL] [Abstract][Full Text] [Related]
11. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma. Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230 [TBL] [Abstract][Full Text] [Related]
12. Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US. Kwak JY; Kim EK; Youk JH; Kim MJ; Son EJ; Choi SH; Oh KK Thyroid; 2008 Jun; 18(6):609-14. PubMed ID: 18578609 [TBL] [Abstract][Full Text] [Related]
13. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas. Zhao L; Sun X; Luo Y; Wang F; Lyu Z Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150 [TBL] [Abstract][Full Text] [Related]
14. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases. Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963 [No Abstract] [Full Text] [Related]
15. Predicting non-small-volume central lymph node metastases (>5 or ≥2 mm) preoperatively in cN0 papillary thyroid microcarcinoma without extrathyroidal extension. Shou JD; Li FB; Shi LH; Zhou L; Xie L; Wang JB Medicine (Baltimore); 2020 Sep; 99(38):e22338. PubMed ID: 32957404 [TBL] [Abstract][Full Text] [Related]
16. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study. Gui CY; Qiu SL; Peng ZH; Wang M J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301 [TBL] [Abstract][Full Text] [Related]
17. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma. Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors. Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049 [TBL] [Abstract][Full Text] [Related]
19. [Risk Factors for central lymph node metastasis in 1 988 papillary thyroid microcarcinoma patients]. Li XJ; Yang L; Ma BL Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):52-57. PubMed ID: 29774686 [No Abstract] [Full Text] [Related]
20. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer. Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]